303 related articles for article (PubMed ID: 35584326)
1. Targeting syndecan-1: new opportunities in cancer therapy.
Yang Z; Chen S; Ying H; Yao W
Am J Physiol Cell Physiol; 2022 Jul; 323(1):C29-C45. PubMed ID: 35584326
[TBL] [Abstract][Full Text] [Related]
2. Advances in the molecular functions of syndecan-1 (SDC1/CD138) in the pathogenesis of malignancies.
Gharbaran R
Crit Rev Oncol Hematol; 2015 Apr; 94(1):1-17. PubMed ID: 25563413
[TBL] [Abstract][Full Text] [Related]
3. Syndecan-1-Induced ECM Fiber Alignment Requires Integrin αvβ3 and Syndecan-1 Ectodomain and Heparan Sulfate Chains.
Yang N; Friedl A
PLoS One; 2016; 11(2):e0150132. PubMed ID: 26909794
[TBL] [Abstract][Full Text] [Related]
4. Molecular and clinical profiles of syndecan-1 in solid and hematological cancer for prognosis and precision medicine.
Akl MR; Nagpal P; Ayoub NM; Prabhu SA; Gliksman M; Tai B; Hatipoglu A; Goy A; Suh KS
Oncotarget; 2015 Oct; 6(30):28693-715. PubMed ID: 26293675
[TBL] [Abstract][Full Text] [Related]
5. Syndecan-1 regulates adipogenesis: new insights in dedifferentiated liposarcoma tumorigenesis.
Zaragosi LE; Dadone B; Michiels JF; Marty M; Pedeutour F; Dani C; Bianchini L
Carcinogenesis; 2015 Jan; 36(1):32-40. PubMed ID: 25344834
[TBL] [Abstract][Full Text] [Related]
6. Mapping the Interactome of the Nuclear Heparan Sulfate Proteoglycan Syndecan-1 in Mesothelioma Cells.
Kumar-Singh A; Shrinet J; Parniewska MM; Fuxe J; Dobra K; Hjerpe A
Biomolecules; 2020 Jul; 10(7):. PubMed ID: 32664515
[TBL] [Abstract][Full Text] [Related]
7. Synstatin: a selective inhibitor of the syndecan-1-coupled IGF1R-αvβ3 integrin complex in tumorigenesis and angiogenesis.
Rapraeger AC
FEBS J; 2013 May; 280(10):2207-15. PubMed ID: 23375101
[TBL] [Abstract][Full Text] [Related]
8. Estrogen receptor α regulates the expression of syndecan-1 in human breast carcinoma cells.
Fleurot E; Goudin C; Hanoux V; Bonnamy PJ; Levallet J
Endocr Relat Cancer; 2019 Jun; 26(6):615-628. PubMed ID: 30978702
[TBL] [Abstract][Full Text] [Related]
9. Follistatin-related protein 1 interacting partner of Syndecan-1 promotes an aggressive phenotype on Oral Squamous cell carcinoma (OSCC) models.
Zandonadi FS; Yokoo S; Granato DC; Rivera C; Macedo CCS; Soares CD; Carnielli CM; Domingues RR; Pauletti BA; Consonni SR; Colleta RD; Paes Leme AF
J Proteomics; 2022 Mar; 254():104474. PubMed ID: 34990821
[TBL] [Abstract][Full Text] [Related]
10. Syndecan-1 deficiency promotes tumor growth in a murine model of colitis-induced colon carcinoma.
Binder Gallimidi A; Nussbaum G; Hermano E; Weizman B; Meirovitz A; Vlodavsky I; Götte M; Elkin M
PLoS One; 2017; 12(3):e0174343. PubMed ID: 28350804
[TBL] [Abstract][Full Text] [Related]
11. Syndecan-1 and -4 influence Wnt signaling and cell migration in human breast cancers.
Pham SH; Pratt K; Okolicsanyi RK; Oikari LE; Yu C; Peall IW; Arif KT; Chalmers TA; Gyimesi M; Griffiths LR; Haupt LM
Biochimie; 2022 Jul; 198():60-75. PubMed ID: 35183674
[TBL] [Abstract][Full Text] [Related]
12. Glycobiology of syndecan-1 in bacterial infections.
Aquino RS; Teng YH; Park PW
Biochem Soc Trans; 2018 Apr; 46(2):371-377. PubMed ID: 29523771
[TBL] [Abstract][Full Text] [Related]
13. Induction of syndecan-1 expression in stromal fibroblasts promotes proliferation of human breast cancer cells.
Maeda T; Alexander CM; Friedl A
Cancer Res; 2004 Jan; 64(2):612-21. PubMed ID: 14744776
[TBL] [Abstract][Full Text] [Related]
14. Role of syndecan-1 and exogenous heparin in hepatoma sphere formation.
Lin SC; Wu CP; Tseng T; Jhang Y; Lee SC
Biochem Cell Biol; 2020 Apr; 98(2):112-119. PubMed ID: 31042409
[TBL] [Abstract][Full Text] [Related]
15. Irradiation-induced angiogenesis is associated with an MMP-9-miR-494-syndecan-1 regulatory loop in medulloblastoma cells.
Asuthkar S; Velpula KK; Nalla AK; Gogineni VR; Gondi CS; Rao JS
Oncogene; 2014 Apr; 33(15):1922-33. PubMed ID: 23728345
[TBL] [Abstract][Full Text] [Related]
16. Syndecan-1 induction in lung microenvironment supports the establishment of breast tumor metastases.
Chute C; Yang X; Meyer K; Yang N; O'Neil K; Kasza I; Eliceiri K; Alexander C; Friedl A
Breast Cancer Res; 2018 Jul; 20(1):66. PubMed ID: 29976229
[TBL] [Abstract][Full Text] [Related]
17. Syndecan-1 is the primary heparan sulfate proteoglycan mediating hepatic clearance of triglyceride-rich lipoproteins in mice.
Stanford KI; Bishop JR; Foley EM; Gonzales JC; Niesman IR; Witztum JL; Esko JD
J Clin Invest; 2009 Nov; 119(11):3236-45. PubMed ID: 19805913
[TBL] [Abstract][Full Text] [Related]
18. Syndecan-1 Promotes Streptococcus pneumoniae Corneal Infection by Facilitating the Assembly of Adhesive Fibronectin Fibrils.
Jinno A; Hayashida A; Jenkinson HF; Park PW
mBio; 2020 Dec; 11(6):. PubMed ID: 33293379
[TBL] [Abstract][Full Text] [Related]
19. Syndecan-1 Acts in Synergy with Tight Junction Through Stat3 Signaling to Maintain Intestinal Mucosal Barrier and Prevent Bacterial Translocation.
Wang Z; Li R; Tan J; Peng L; Wang P; Liu J; Xiong H; Jiang B; Chen Y
Inflamm Bowel Dis; 2015 Aug; 21(8):1894-907. PubMed ID: 25970544
[TBL] [Abstract][Full Text] [Related]
20. Sulfated syndecan 1 is critical to preventing cellular senescence by modulating fibroblast growth factor receptor endocytosis.
Kang D; Jung SH; Lee GH; Lee S; Park HJ; Ko YG; Kim YN; Lee JS
FASEB J; 2020 Aug; 34(8):10316-10328. PubMed ID: 32530114
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
